BradburyAWMoakesCAPopplewellM,et al. BASIL-2 Investigators. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401:1798-1809.
2.
FarberAMenardMTConteMS,et al. BEST-CLI Investigators. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387:2305-2316.
3.
PopplewellMAMeechamLDaviesHOB,et al.Editor’s choice- Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) prospective cohort study and the generalisability of the BASIL-2 randomised controlled trial. Eur J Vasc Endovasc Surg. 2024;67:146-152.
4.
ParaskevasKIVeithFJ. Expansion of bypass as a revascularization option for patients with chronic limb-threatening ischemia. Angiology. 2023;74:809-811.
5.
ConteMSBradburyAWKolhP,et al.GVG writing group for the joint guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS). Eur J Vasc Endovasc Surg. 2019;58:S1-S109.
6.
ParaskevasKIde BorstGJVeithFJ. Why randomized controlled trials do not always reflect reality. J Vasc Surg. 2019;70:607-614.
7.
VeithFJParaskevasKI. The spinning of randomized controlled trials. J Vasc Surg. 2022;76:306.
8.
GargKKaszubskiPAMoridzadehR,et al.Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia. J Vasc Surg. 2014;59:392-399.
9.
KatibNThomasSDLennoxAFYangJLVarcoeRL. An endovascular-first approach to the treatment of critical limb ischemia results in superior limb salvage rates. J Endovasc Ther. 2015;22:473-481.
10.
RiccoJBRoigerRJSchneiderF,et al.Editor’s choice - infra-inguinal endovascular revascularisation and bypass surgery for chronic limb threatening ischaemia: a retrospective European multicentre cohort study with propensity score matching. Eur J Vasc Endovasc Surg. 2023;66:531-540.
11.
BisdasTBorowskiMStavroulakisKTorselloGCRITISCH Collaborators. Endovascular therapy versus bypass surgery as first-line treatment strategies for critical limb ischemia: results of the interim analysis of the CRITISCH registry. JACC Cardiovasc Interv. 2016;9:2557-2565.
12.
MathlouthiAElsayedNAl-NouriOFarberAMalasMB. Outcomes of endovascular-first versus bypass-first approach for patients with chronic limb-threatening ischemia using a medicare-linked database. Ann Vasc Surg. 2022;85:119-124.